Several coherent findings showed that ERβ expression decreases in precancerous and cancerous breast lesions [6,11,12,13,14,15], and is reduced or completely absent in invasive breast tumors [13,16], an event common also to other cancers such as colon, lung, ovary, and prostate [17,18]. Here, ESR2 is linked to cancer.